Quarterly report pursuant to Section 13 or 15(d)

Condensed Balance Sheet

v3.3.0.814
Condensed Balance Sheet - USD ($)
Sep. 30, 2015
Dec. 31, 2014
Current Assets:    
Cash and cash equivalents $ 12,450,387 $ 9,826,245
Marketable securities 9,006,669 22,872,051
Prepaid expenses and other current assets 1,475,757 730,987
Total Current Assets 22,932,813 33,429,283
Security Deposits 30,785 25,681
Equipment, Net 110,653 78,096
Total Assets 23,074,251 33,533,060
Current Liabilities:    
Accounts payable and accrued expenses 3,238,063 2,459,263
Deferred Research and Development Arrangement 543,750 600,000
Other Liabilities 109,732 124,955
Warrant Liabilities 1,476,497 3,768,351
Total Liabilities $ 5,368,042 $ 6,952,569
Commitments and Contingencies (note 14)
Stockholders' Equity:    
Preferred stock, par value $0.0001, 100,000,000 authorized shares, none issued and outstanding
Common stock, par value $0.0001, 500,000,000 authorized shares, 180,860,333 and 178,366,533 issued and 180,747,118 and 178,253,318 outstanding $ 18,086 $ 17,837
Additional paid-in capital 120,674,473 118,057,019
Accumulated other comprehensive income (loss) 6,769 (33,647)
Accumulated deficit (102,864,709) (91,332,308)
Treasury stock, 113,215 shares, at cost (128,410) (128,410)
Total Stockholders' Equity 17,706,209 26,580,491
Total Liabilities and Stockholders' Equity $ 23,074,251 $ 33,533,060